Frontiers in nephrology: Viewing the kidney through the heart - Endothelial dysfunction in chronic kidney disease

Journal of the American Society of Nephrology

Volumn 18, Issue 11, 2007, Pages 2833-2835

  Goligorsky, Michael S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GESTAGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CLINICAL STUDY; DISEASE CLASSIFICATION; ENDOTHELIAL DYSFUNCTION; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SUDDEN DEATH;

EID: 35848939825     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007050598     Document Type: Short Survey

References (25)

1. Parry CH: An Inquiry into the Symptoms and Causes of the Syncope Anginosa, Bath, R Cruttwell, 1799
2. Lindner A, Charra B, Sharrard D, Scribner B: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697-701, 1974
3. Levey A, Beto J, Coronado B, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know, what do we need to learn, where do we go from here? Am J Kidney Dis 32: 853-906, 1998
4. Shik J, Parfrey P: The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens 14: 550-557, 2005
5. Ritz E, McClellan W: Overview: Increased cardiovascular risk in patients with minor renal dysfunction - An emerging issue with far-reaching consequences. J Am Soc Nephrol 15: 513-516, 2004
6. Gokce N, Keaney J, Vita J: Endotheliopathies: Clinical manifestations of endothelial dysfunction. In: Thrombosis and Hemorrhage, edited by Loscalzo J, Shafer A, Baltimore, Williams & Wilkins, 1998, pp 901-924
7. Bonetti P, Lerman L, Lerman A: Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-175, 2003
8. Furchgott RF, Zawadzki JW: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980
9. Ludmer P, Selwyn A, Shook T, Wayne R, Mudge G, Alexander R, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315: 1046-1051, 1986
10. Gossl M, Lerman LO, Lerman A: Frontiers in nephrology: Early atherosclerosis - A view beyond the lumen. J Am Soc Nephrol 18: 000-000, 2007
11. Tongers J, Losordo DW: Frontiers in nephrology: Therapeutic applications of endothelial progenitor cells - Time to reconsider. J Am Soc Nephrol 18: 000-000, 2007
12. Ashley EA, Spin J, Tabibiazar R, Quertermous T: Frontiers in nephrology: Genomic approaches to understanding the molecular basis of atherosclerosis. J Am Soc Nephrol 18: 000-000, 2007
13. Letts G, Loscalzo J: Frontiers in nephrology: Targeting inflammation using novel nitric oxide donors. J Am Soc Nephrol 18: 000-000, 2007
14. Chen J, Brodsky S, Goligorsky DM, Hampel D, Li H, Gross SS, Goligorsky MS: Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res 90: 1290-1298, 2002
15. Li H, Lewis A, Brodsky S, Rieger R, Iden C Goligorsky MS: Homocysteine induces HMGCoA reductase in vascular endothelial cells: A mechanism for development of atherosclerosis. Circulation 105: 1037-1043, 2002
16. Zhang X, Jin H, Li H, Ebin Z, Brodsky S, Goligorsky MS: Effects of homocysteine on nitric oxide production by endothelial cells. Am J Physiol 279: F671-F678, 2000
17. Chen J, Brodsky S, Hampel D, Li H, Weinstein T, Gafter U, Norman J, Fine L, Goligorsky MS: Delayed branching of endothelial capillary cords in glycated collagen I is mediated by the early induction of PAI-1. Am J Physiol 281: F71-F80, 2001
18. Li H, Brodsky S, Brink P, Nasjletti A, Goligorsky MS: Paradoxical overexpression and translocation of connexin-43 in homocysteine-treated endothelial cells. Am J Physiol Heart Circ Physiol 282: H2124-H2133, 2002
19. Li H, Goligorsky MS: Endothelial gene responses to homocysteine: Relation to atherosclerosis. Exp Nephrol 10: 164-169, 2002
20. Smirnova I, Sawamura T, Goligorsky MS: Upregulation of LOX-1 in endothelial cells by nitric oxide deficiency. Am J Physiol Renal Physiol 287: F25-F32, 2004
21. O'Riordan E, Mendelev N, Patschan S, Chander P, Goligorsky MS: Profibrotic effect of chronic NOS inhibition is associated with the mesenchymal transformation of NO-deficient endothelial cells. Am J Physiol Heart Circ Physiol 292: H285-H294, 2007
22. Brodsky S, Gaelikman O, Chen J, Zhang F, Togashi N, Crabtree M, Gross S, Nasjletti A, Goligorsky MS: Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ Res 94: 377-384, 2004
23. Voetsch B, Loscalzo J: Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 24: 216-229, 2004
24. Tabibiazar R, Wagner R, Deng A, Tsao PS, Quertermous T: Proteomic profile of serum inflammatory markers accurately predicts atherosclerosis in mice. Physiol Genomics 25: 194-202, 2006
25. Sabatine M, Liu E, Morrow D: Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112: 3868-3875, 2005